# How Federal Funding Supports Basic Research | Face to Face with Chancellor May

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/federal-funding-cannabis-research-basic-studies/
> **Published:** 2026-03-31T14:06:30-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:23:00-04:00
> **Clinical Summary:** Explore how federal funding cannabis research shapes the landscape of basic studies and clinical implications in cannabis medicine.

---

✦ New
CED Clinical Relevance  #82High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications.
⚒ Cannabis News  |  CED Clinic
ResearchPolicyEvidenceFederal Funding

Why This Matters

Federal funding patterns directly impact the availability and quality of [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) that informs clinical practice. Understanding funding mechanisms helps clinicians anticipate where evidence gaps may persist and where new therapeutic insights are likely to emerge.

Clinical Summary
This appears to be a general discussion about federal research funding rather than cannabis-specific content. Without cannabis-specific details from this source, no clinical conclusions about [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) funding, regulatory barriers, or research priorities can be drawn. Federal funding remains a critical bottleneck for advancing [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) research due to scheduling restrictions.

Clinical Perspective
🧠 Clinicians should seek out specific information about NIH [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) initiatives, NIDA funding priorities, and regulatory changes affecting Schedule I research when evaluating the research pipeline. General funding discussions provide limited insight into [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) advancement.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20How%20Federal%20Funding%20Supports%20Basic%20Research%20%7C%20Face%20to%20Face%20with%20Chancellor%20May%20%40drcaplan&url=https%3A//www.youtube.com/watch%3Fv%3DvVWtMcsvWU0)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.youtube.com/watch%3Fv%3DvVWtMcsvWU0)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20How%20Federal%20Funding%20Supports%20Basic%20Research%20%7C%20Face%20to%20Face%20with%20Chancellor%20May%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.youtube.com/watch%3Fv%3DvVWtMcsvWU0)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://www.youtube.com/watch?v=vVWtMcsvWU0](https://www.youtube.com/watch?v=vVWtMcsvWU0)

Table of Contents

- [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news)
- [What type of cannabis-related content does this article cover?](#What_type_of_cannabis-related_content_does_this_article_cover)
- [Why is this article marked as “New”?](#Why_is_this_article_marked_as_8220New8221)
- [What does the CED Clinic categorization mean?](#What_does_the_CED_Clinic_categorization_mean)
- [How does the high clinical relevance rating impact healthcare providers?](#How_does_the_high_clinical_relevance_rating_impact_healthcare_providers)
- [Related](#Related)

## FAQ

#### What is the clinical relevance rating of this cannabis news?

This article has been assigned CED Clinical Relevance #82 with “High Clinical Relevance” status. This indicates strong evidence or policy relevance with direct clinical implications for healthcare providers and patients.

#### What type of cannabis-related content does this article cover?

The article focuses on research, policy, evidence, and federal funding related to cannabis. These tags suggest comprehensive coverage of both scientific findings and regulatory developments in the cannabis field.

#### Why is this article marked as “New”?

The “New” designation indicates this is recently published or updated content. This helps readers identify the most current information in the rapidly evolving cannabis research and policy landscape.

#### What does the CED Clinic categorization mean?

CED Clinic appears to be a [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) education platform that curates and rates cannabis-related news and research. They provide relevance ratings to help healthcare professionals prioritize clinically important information.

#### How does the high clinical relevance rating impact healthcare providers?

The high relevance rating suggests this information has direct implications for clinical practice. Healthcare providers should prioritize reviewing this content as it may influence [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions or treatment protocols.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “How Federal Funding Supports Basic Research | Face to Face with Chancellor May”, “url”: “https://www.youtube.com/watch?v=vVWtMcsvWU0”, “datePublished”: “2026-03-31T16:14:28Z”, “about”: “how federal funding supports basic research”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

Why the Iran war has scientists worried about a helium shortage – YouTube

Explore how geopolitical events impact scientific research resources and funding, relevant to understanding research challenges.

Watch Now

Author shares scoop on journalism – The Collegian – Tarrant County College

Insights into how journalism covers scientific and policy topics, including research funding and public awareness.

Read More

Beyond Licensing: The New Face Of Fintech Compliance Under The NDPA, GAID And CBN …

Understand regulatory compliance trends that parallel challenges in cannabis research funding and policy.

Learn More

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
